Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension?

Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension?

Ker, James A.
URI: http://hdl.handle.net/2263/50030
Date: 2015

Abstract:

The renin-angiotensin system (RAS) and angiotensin II, in particular, play a central role and have been implicated in the spectrum of cardiovascular disease (CVD), beginning with hypertension, diabetes mellitus, atherosclerosis, myocardial infarction (MI), strokes and heart failure.

Show full item record

Files in this item

Icon
Name: Ker_Is_2015.pdf
Size: 50.75Kb
Format: PDF
Description: Article
View/Open

This item appears in the following Collection(s)